Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
close

GLYXAMBI - - 30

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
A10BD19 B Linagliptin - 5mg, Empagliflozin - 25mg 9827 178818/1 GLYXAMBI 30 Tablet, film coated Oral Mersaco Boehringer Ingelheim Pharma GmbH & Co KG Germany 4,162,216 L.L 23.08 B Boehringer Ingelheim Pty Ltd Australia 2/5/2024

Drugs With Same Ingredients

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
A10BD19 B Linagliptin - 5mg, Empagliflozin - 25mg 11434 142722/1 GLYXAMBI 30 Tablet, film coated Oral Mersaco Rottendorf Pharma GmbH Germany 6,403,410 L.L 23.08 B Boehringer Ingelheim International GmbH Germany 2/5/2024
Sitemap
© Copyrights reserved to Ministry of Public Health 2024